The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...
Act" was unveiled by a group of bipartisan lawmakers Tuesday, aimed at reforming the incentive structure for Pharmacy Benefit ...
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
President Trump’s Justice Department will defend Biden’s Inflation Reduction Act and its dangerous price controls on ...
encourages them to drive up the list price of drugs to increase profits. "Pharmacy benefit managers (PBMs) have excessive influence over the prices patients pay at the pharmacy counter," said ...
Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...
Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...